Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Neuphoria Therapeutics Inc. (NEUP) had Pre-Tax Income of $-9.94M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-9.91M |
|
-- |
|
-- |
|
$5.65M |
|
$-5.65M |
|
$-4.29M |
|
|
Pre-Tax Income |
$-9.94M |
$-9.94M |
|
$-9.91M |
|
$-9.91M |
|
$-9.91M |
|
$-9.91M |
|
$-5.65M |
|
$-5.49M |
|
2.25M |
|
2.25M |
|
$-4.41 |
|
$-4.41 |
|
| Balance Sheet Financials | |
$13.95M |
|
$0.00M |
|
$13.39M |
|
$27.34M |
|
$5.12M |
|
-- |
|
$9.71M |
|
$14.83M |
|
$12.51M |
|
$-0.80M |
|
$12.51M |
|
2.36M |
|
| Cash Flow Statement Financials | |
$-3.79M |
|
-- |
|
$3.25M |
|
$14.29M |
|
$13.73M |
|
$-0.56M |
|
$0.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-79.19% |
|
1232.68% |
|
-36.23% |
|
-79.19% |
|
$5.31 |
|
$-1.69 |
|
$-1.69 |
|